{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:36:45Z","timestamp":1792643805128,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009425","name":"Landsteiner Foundation for Blood Transfusion Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.transci.2019.102704","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T09:06:53Z","timestamp":1577783213000},"page":"102704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia"],"prefix":"10.1016","volume":"59","author":[{"given":"T.W.","family":"de Vos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Winkelhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"de Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lopriore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Oepkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2019.102704_bib0005","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/trf.13550","article-title":"Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia: a case series and review of the literature","volume":"56","author":"Winkelhorst","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.102704_bib0010","first-page":"1","article-title":"Perinatal outcome and long-term neurodevelopment after intracranial haemorrhage due to fetal and neonatal alloimmune thrombocytopenia","author":"Winkelhorst","year":"2018","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.transci.2019.102704_bib0015","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1471-0528.2010.02657.x","article-title":"Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review","volume":"117","author":"Kamphuis","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.transci.2019.102704_bib0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1542\/peds.2013-3320","article-title":"Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review","volume":"133","author":"Kamphuis","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.transci.2019.102704_bib0025","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2016-10-739656","article-title":"Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review","volume":"129","author":"Winkelhorst","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.102704_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41372-019-0360-7","article-title":"Postnatal intervention for the treatment of FNAIT: a systematic review","author":"Baker","year":"2019","journal-title":"J Perinatol"},{"key":"10.1016\/j.transci.2019.102704_bib0035","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/intimm\/13.8.993","article-title":"The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans","volume":"13","author":"Firan","year":"2001","journal-title":"Int Immunol"},{"key":"10.1016\/j.transci.2019.102704_bib0040","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1182\/blood-2010-05-284919","article-title":"Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy","volume":"116","author":"Chen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.102704_bib0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1034\/j.1600-0609.2003.00025.x","article-title":"Anti-HPA-1a-mediated platelet phagocytosis by monocytes in vitro and its inhibition by Fc gamma receptor (FcgammaR) reactive reagents","volume":"70","author":"Wiener","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.transci.2019.102704_bib0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1034\/j.1600-0609.2000.065006399.x","article-title":"HPA-1a-mediated platelet interaction with monocytes in vitro: involvement of Fcgamma receptor (FcgammaR) classes and inhibition by humanised monoclonal anti-FcgammaRI H22","volume":"65","author":"Wiener","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.transci.2019.102704_bib0055","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2014-11-611020","article-title":"Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies","volume":"126","author":"Liu","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.102704_bib0060","series-title":"All HPA genetic information. Immuno polymorphism database","year":"2019"},{"key":"10.1016\/j.transci.2019.102704_bib0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/vox.12085","article-title":"Human platelet antigens - 2013","volume":"106","author":"Curtis","year":"2014","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2019.102704_bib0070","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1055\/s-0038-1657598","article-title":"Mechanisms initiating platelet thrombus formation","volume":"78","author":"Ruggeri","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.transci.2019.102704_bib0075","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1172\/JCI114082","article-title":"The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33\/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing","volume":"83","author":"Newman","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.transci.2019.102704_bib0080","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1172\/JCI111789","article-title":"A monoclonal antibody to human platelet glycoprotein IIIa detects a related protein in cultured human endothelial cells","volume":"75","author":"Thiagarajan","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.transci.2019.102704_bib0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2141.1987.00355.x-i1","article-title":"The platelet alloantigen Zwa or PlA1 is expressed by cultured endothelial cells","volume":"66","author":"Leeksma","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2019.102704_bib0090","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/HUMREP\/10.6.1571","article-title":"Cell adhesion molecules on the oocyte and preimplantation human embryo","volume":"10","author":"Campbell","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.transci.2019.102704_bib0095","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1586\/ehm.10.49","article-title":"Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention","volume":"3","author":"Skogen","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.transci.2019.102704_bib0100","first-page":"3","article-title":"Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry","author":"Tiller","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.transci.2019.102704_bib0105","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1537-2995.2008.01832.x","article-title":"Ultrastructural localization of glycoprotein IIIa (GPIIIa, beta 3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy","volume":"48","author":"Kumpel","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.102704_bib0110","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood-2008-09-178475","article-title":"T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cells","volume":"113","author":"Ahlen","year":"2009","journal-title":"Blood"},{"issue":"183","key":"10.1016\/j.transci.2019.102704_bib0115","first-page":"677","article-title":"Evidence for the specificity for platelet HPA-1a alloepitope and the presenting HLA-DR52a of diverse antigen-specific helper T cell clones from alloimmunized mothers","author":"Rayment","year":"2009","journal-title":"J Immunol (Baltimore, Md\u202f: 1950)"},{"key":"10.1016\/j.transci.2019.102704_bib0120","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(95)90531-6","article-title":"Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin\/MGDF in megakaryocyte development","volume":"81","author":"Shivdasani","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.transci.2019.102704_bib0125","doi-asserted-by":"crossref","first-page":"15724","DOI":"10.18632\/oncotarget.4757","article-title":"Angiogenesis and bleeding disorders in FNAIT","volume":"6","author":"Yougbare","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.transci.2019.102704_bib0130","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molimm.2008.10.015","article-title":"HPA-1a alloantibodies reduce endothelial cell spreading and monolayer integrity","volume":"46","author":"van Gils","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.transci.2019.102704_bib0135","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/ATVBAHA.116.307281","article-title":"Antiendothelial alphavbeta3 antibodies are a major cause of intracranial bleeding in fetal\/neonatal alloimmune thrombocytopenia","volume":"36","author":"Santoso","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.transci.2019.102704_bib0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jcp.55.4.289","article-title":"Neonatal alloimmune thrombocytopenia in the Irish population: a discrepancy between observed and expected cases","volume":"55","author":"Davoren","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.transci.2019.102704_bib0145","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1471-0528.2008.02068.x","article-title":"Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme","volume":"116","author":"Tiller","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.transci.2019.102704_bib0150","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM199311113292005","article-title":"Fetal thrombocytopenia and its relation to maternal thrombocytopenia","volume":"329","author":"Burrows","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2019.102704_bib0155","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2141.1995.tb05597.x","article-title":"Maternal alloimmunization against fetal platelet antigens: a prospective study","volume":"90","author":"Panzer","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2019.102704_bib0160","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1182\/blood.V89.12.4402","article-title":"Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group","volume":"89","author":"Dreyfus","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.102704_bib0165","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2141.1998.00628.x","article-title":"Neonatal thrombocytopenia: incidence and characterization of maternal antiplatelet antibodies by MAIPA assay","volume":"100","author":"de Moerloose","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2019.102704_bib0170","first-page":"441","article-title":"Thrombocytopenia in term infants: a population-based study","volume":"95","author":"Sainio","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.transci.2019.102704_bib0175","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1034\/j.1600-0609.2000.09007.x","article-title":"Neonatal and maternal thrombocytopenia: incidence and immune background","volume":"64","author":"Uhrynowska","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.transci.2019.102704_bib0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1399-0039.1985.tb00936.x","article-title":"Immunogenicity of and immune response to the human platelet antigen Zwa is strongly associated with HLA-B8 and DR3","volume":"26","author":"Mueller-Eckhardt","year":"1985","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.transci.2019.102704_bib0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000415432","article-title":"Allo-immune thrombocytopenias, definition of a group at risk; a prospective study","author":"Reznikoff-Etievant","year":"1988","journal-title":"Curr Stud Hematol Blood Transfus"},{"key":"10.1016\/j.transci.2019.102704_bib0190","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.1990.tb02567.x","article-title":"Alloimmunization to the PlA1 platelet antigen: results of a prospective study","volume":"74","author":"Blanchette","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2019.102704_bib0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2141.1995.tb05152.x","article-title":"Antenatal screening for fetal alloimmune thrombocytopenia: the results of a pilot study","volume":"90","author":"Doughty","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2019.102704_bib0200","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/s-2007-994382","article-title":"Screening primiparous women and newborns for fetal\/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group","volume":"13","author":"Durand-Zaleski","year":"1996","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.transci.2019.102704_bib0205","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood.V92.7.2280","article-title":"The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening","volume":"92","author":"Williamson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.102704_bib0210","first-page":"492","article-title":"Antenatal screening for human platelet antigen-1a: results of a prospective study at a large maternity hospital in Ireland","volume":"110","author":"Davoren","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.transci.2019.102704_bib0215","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.0042-9007.2003.00363.x","article-title":"Antenatal screening of unselected pregnant women for HPA-1a antigen, antibody and alloimmune thrombocytopenia","volume":"85","author":"Maslanka","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2019.102704_bib0220","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1537-2995.2005.00645.x","article-title":"Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a","volume":"45","author":"Turner","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.102704_bib0225","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2006-08-040121","article-title":"A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia","volume":"110","author":"Kjeldsen-Kragh","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.102704_bib0230","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.5114\/aoms.2016.63600","article-title":"Identification and follow-up of pregnant women with platelet-type human platelet antigen (HPA)-1bb alloimmunized with fetal HPA-1a","volume":"14","author":"Debska","year":"2018","journal-title":"Arch Med Sci"},{"issue":"44","key":"10.1016\/j.transci.2019.102704_bib0235","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1537-2995.2004.04026.x","article-title":"Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia","author":"Davoren","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.102704_bib0240","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-3148.2004.00535.x","article-title":"The natural history of maternal immunization against foetal platelet alloantigens","volume":"14","author":"Ohto","year":"2004","journal-title":"Transfusion Med (Oxford, England)"},{"issue":"49","key":"10.1016\/j.transci.2019.102704_bib0245","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1111\/j.1537-2995.2009.02246.x","article-title":"Alloantibodies against low-frequency human platelet antigens do not account for a significant proportion of cases of fetomaternal alloimmune thrombocytopenia: evidence from 1054 cases","author":"Ghevaert","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.102704_bib0250","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/OGX.0b013e3182947ce4","article-title":"Mechanisms and prevention of alloimmunization in pregnancy","volume":"68","author":"Kjeldsen-Kragh","year":"2013","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.transci.2019.102704_bib0255","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1537-2995.2007.01208.x","article-title":"Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia","volume":"47","author":"Ghevaert","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.102704_bib0260","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/trf.14394","article-title":"Intracranial hemorrhages in neonates born from 32 weeks of gestation-low frequency of associated fetal and neonatal alloimmune thrombocytopenia: a register-based study","volume":"58","author":"Refsum","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.102704_bib0265","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1423-0410.2003.00302.x","article-title":"Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?","volume":"84","author":"Radder","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2019.102704_bib0270","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-204393","article-title":"A rare manifestation of neonatal alloimmune thrombocytopaenia","volume":"2014","author":"Jeronimo","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.transci.2019.102704_bib0275","first-page":"70","article-title":"Neonatal alloimmune thrombocytopenic purpura caused by anti-HPA-1a alloantibodies. Case report","volume":"123","author":"Tomicic","year":"2001","journal-title":"Lijec Vjesn"},{"key":"10.1016\/j.transci.2019.102704_bib0280","article-title":"Progress in development of platelet antibody detection","author":"Porcelijn","year":"2019","journal-title":"Transfusion Apheresis Sci"},{"key":"10.1016\/j.transci.2019.102704_bib0285","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/vox.12725","article-title":"Maternal HPA-1a antibody level and its role in predicting the severity of fetal\/neonatal alloimmune thrombocytopenia: a systematic review","volume":"114","author":"Kjaer","year":"2019","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2019.102704_bib0290","article-title":"Fetal and neonatal alloimmune thrombocytopenia \u2013 the Norwegian management model","author":"Tiller","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2019.102704_bib0295","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1537-2995.2007.01273.x","article-title":"HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia","volume":"47","author":"Ghevaert","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.102704_bib0300","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(84)90614-7","article-title":"Prenatal treatment of alloimmune thrombocytopenia","volume":"2","author":"Daffos","year":"1984","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.transci.2019.102704_bib0305","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM198811243192103","article-title":"Antenatal treatment of neonatal alloimmune thrombocytopenia","volume":"319","author":"Bussel","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2019.102704_bib0310","article-title":"The use of IVIg in fetal and neonatal alloimmune thrombocytopenia \u2013 principles and mechanisms","author":"Wabnitza","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2019.102704_bib0315","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bjh.15813","article-title":"Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach","volume":"185","author":"Lieberman","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2019.102704_bib0320","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000380907","article-title":"Low-dose versus standard-dose intravenous immunoglobulin to prevent fetal intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia: a randomized trial","volume":"38","author":"Paridaans","year":"2015","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.transci.2019.102704_bib0325","first-page":"1783","article-title":"Effects of antepartum therapy for fetal alloimmune thrombocytopenia on maternal lifestyle","volume":"29","author":"Rossi","year":"2016","journal-title":"J Maternal-Fetal Neonatal Med"},{"key":"10.1016\/j.transci.2019.102704_bib0330","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1055\/s-0037-1607055","article-title":"IVIG-associated maternal pancytopenia during treatment for neonatal alloimmune thrombocytopenia","volume":"7","author":"Herrmann","year":"2017","journal-title":"AJP Rep"},{"key":"10.1016\/j.transci.2019.102704_bib0335","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ajog.2004.02.002","article-title":"The immunologic profile of infants born after maternal immunoglobulin treatment and intrauterine platelet transfusions for fetal\/neonatal alloimmune thrombocytopenia","volume":"191","author":"Radder","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.transci.2019.102704_bib0340","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.earlhumdev.2004.05.007","article-title":"Follow up of children after antenatal treatment for alloimmune thrombocytopenia","volume":"80","author":"Radder","year":"2004","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.transci.2019.102704_bib0345","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.AOG.0000192404.25780.68","article-title":"Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia","volume":"107","author":"Berkowitz","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.transci.2019.102704_bib0350","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1471-0528.2006.00993.x","article-title":"Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia?","volume":"113","author":"van den Akker","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.transci.2019.102704_bib0355","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/j.1537-2995.2011.03480.x","article-title":"Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model","volume":"52","author":"Tiller","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.102704_bib0360","article-title":"Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia","author":"Kj\u00e6r","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2019.102704_bib0365","first-page":"1111","article-title":"Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration","volume":"10","author":"Smith","year":"2018","journal-title":"mAbs"},{"key":"10.1016\/j.transci.2019.102704_bib0370","series-title":"A study to evaluate the safety, efficacy, pharmacokinetics and pharmacodynamics of M281 administered to pregnant women at high risk for early onset severe hemolytic disease of the fetus and newborn (HDFN)","year":"2019"},{"key":"10.1016\/j.transci.2019.102704_bib0375","doi-asserted-by":"crossref","first-page":"F348","DOI":"10.1136\/fetalneonatal-2011-300763","article-title":"Thrombocytopaenia and intraventricular haemorrhage in very premature infants: a tale of two cities","volume":"97","author":"von Lindern","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.transci.2019.102704_bib0380","doi-asserted-by":"crossref","first-page":"e1095","DOI":"10.1542\/peds.2009-0582","article-title":"Severe thrombocytopenia in the NICU","volume":"124","author":"Baer","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.transci.2019.102704_bib0385","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1542\/peds.2009-0332","article-title":"Prospective, observational study of outcomes in neonates with severe thrombocytopenia","volume":"124","author":"Stanworth","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.transci.2019.102704_bib0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2018.10.001","article-title":"Are thrombocytopenia and platelet transfusions associated with major bleeding in preterm neonates? A systematic review","volume":"36","author":"Fustolo-Gunnink","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.transci.2019.102704_bib0395","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa1807320","article-title":"Randomized trial of platelet-transfusion thresholds in neonates","volume":"380","author":"Curley","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2019.102704_bib0400","article-title":"Treatment and outcomes of fetal\/neonatal alloimmune thrombocytopenia: a nationwide cohort study in newly detected cases","author":"Winkelhorst","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2019.102704_bib0405","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/s-2006-954958","article-title":"Long-term effects of fetal and neonatal alloimmune thrombocytopenia and its antenatal treatment on the medical and developmental outcomes of affected children","volume":"23","author":"Ward","year":"2006","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.transci.2019.102704_bib0410","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2471\/BLT.07.050112","article-title":"Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years","volume":"86","author":"Andermann","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.transci.2019.102704_bib0415","series-title":"HIP-study (HPA-screening in pregnancy): protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal\/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk","author":"Winkelhorst","year":"2019"},{"key":"10.1016\/j.transci.2019.102704_bib0420","series-title":"Towards routine HPA-screening in pregnancy to prevent FNAIT (HIP)","author":"Oepkes","year":"2019"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219302770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219302770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:52:26Z","timestamp":1761468746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050219302770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1473050219302770"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2019.102704","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2019.102704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102704"}}